Connect With a Global Community of DDR Experts
The 9th DDR Inhibitors Summit is the only industry-led meeting exclusively dedicated to advancing DDR-targeted drug development, making it the premier platform for solution providers to connect with the innovators shaping the future of oncology. Over three content-rich days, this highly specialized forum brings together 80+ senior decision-makers from leading pharma, biotech, and academic institutions, all actively seeking cutting-edge technologies, strategic partnerships, and services to accelerate their DDR programs.
As the field moves beyond PARP inhibitors toward novel targets like ATR, WEE1, DNA-PK, and replication stress pathways, demand for precision diagnostics, biomarker-driven strategies, CRO support, and integrated discovery platforms has never been greater. By partnering with us, you’ll position your brand at the forefront of innovation, showcase your expertise to an audience eager for collaboration, and gain direct access to the people driving next-generation DDR therapeutics.
Whether your solutions enable smarter trial design, predictive biomarker development, or advanced drug discovery, this summit offers an unparalleled opportunity to demonstrate value, build relationships, and influence purchasing decisions in a rapidly evolving market. Join us to connect, collaborate, and shape the future of DDR-targeted oncology.
Addressing Key Challenges in DDR Development:
1
Safety & Resistance: Showcase how your solutions help overcome toxicity and resistance in DDR combinations.
2
Biomarker Integration: Position your diagnostics to support smarter patient selection and dosing.
3
Discovery Acceleration: Present your platforms that enable rapid identification and optimization of DDR inhibitors.
Addressing Key Challenges in DDR Development:
Amplify Your Industry Presence
Be seen by the right people at the right time and position your brand in front of a highly targeted audience of 90+ DDR-focused drug developers and decision-makers.
Stand Out Where It Matters Most
Differentiate your solutions in a niche, expert-led forum dedicated exclusively to DDR-targeted oncology innovation.
Unlock New Business Pathways
Build relationships that lead to commercial partnerships, pilot projects, and long-term collaborations with biopharma innovators.
Stay Ahead of the Innovation Curve
Gain early insights into emerging DDR targets, biomarker strategies, and combination approaches shaping the future of oncology.
Connect With the Minds Shaping DDR Therapeutics
Engage with leading scientists, clinical developers, and biotech founders driving the next wave of DDR breakthroughs.
Key Services & Solutions
Our attendees from DDR biopharma are looking for service and solution providers with capabilities in the below areas but not limited to:
Diagnostics & Biomarker Solutions
Effective CROs
Integrated Drug Discovery Platforms
Hear What Our Past Sponsors Have to Say
The presentations and speakers were great, as was the networking. This is one of the top DDR-focused conferences, and really important to keep the field moving forward.
Well organised, focussed, small, good variety of talks.
Audience Composition
Company Type
Attendee Seniority
Attending Companies Include
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Anika Johal
Partnerships Director